Equities

Eiken Chemical Co Ltd

Eiken Chemical Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)2,172.00
  • Today's Change3.00 / 0.14%
  • Shares traded98.40k
  • 1 Year change+39.68%
  • Beta0.3587
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Eiken Chemical Co Ltd's revenues fell -7.44% from 43.27bn to 40.05bn. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from 5.74bn to 2.63bn, a -54.08% decrease.
Gross margin41.23%
Net profit margin5.88%
Operating margin7.07%
Return on assets3.59%
Return on equity4.81%
Return on investment4.41%
More ▼

Cash flow in JPYView more

In 2024, cash reserves at Eiken Chemical Co Ltd fell by 5.10bn. However, the company earned 3.81bn from its operations for a Cash Flow Margin of 9.51%. In addition the company used 2.21bn on investing activities and also paid 6.69bn in financing cash flows.
Cash flow per share91.09
Price/Cash flow per share25.63
Book value per share1,339.12
Tangible book value per share1,318.76
More ▼

Balance sheet in JPYView more

Eiken Chemical Co Ltd appears to have a strong balance sheet with enough cash in the capital structure to pay down 100% of the liabilities.
Current ratio2.85
Quick ratio2.13
Total debt/total equity0.0647
Total debt/total capital0.0608
More ▼

Growth rates in JPY

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items fell by -53.79%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)2.38%
Div growth rate (5 year)11.20%
Payout ratio (TTM)38.67%
EPS growth(5 years)-5.19
EPS (TTM) vs
TTM 1 year ago
-20.32
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.